Midazolam Hydrochloride Inje · #14 of 35 active shortages by FDA posting duration
FDA lists Midazolam Hydrochloride Inje as Active Shortage (Gland Pharma Limited).
Availability on file: Available
Midazolam Hydrochloride Injection: Active Shortage
Available 30 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Midazolam Hydrochloride Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 2 mg/2 mL (NDC 70860-600-02)
- Package NDC
- 70860-600-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 2, 2020
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Anesthesia, Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Distributed by Sagent Pharmaceuticals: 1-866-625-1618
Full Drug Profile
midazolam
Side effects, interactions, warnings & more
Nearby, Other Midazolam Shortage Records
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Distributed by Sagent Pharmaceuticals: 1-866-625-1618. General shortage guidance lives on the tracker hub.